SEOM clinical guideline for the management of cutaneous melanoma (2020)


Por: Majem, M, Manzano, JL, Marquez-Rodas, I, Mujika, K, Munoz-Couselo, E, Perez-Ruiz, E, de la Cruz-Merino, L, Espinosa, E, Gonzalez-Cao, M, Berrocal, A

Publicada: 1 may 2021 Ahead of Print: 1 mar 2021
Resumen:
Melanoma affects about 6000 patients a year in Spain. A group of medical oncologists from Spanish Society of Medical Oncology (SEOM) and Spanish Multidisciplinary Melanoma Group (GEM) has designed these guidelines to homogenize the management of these patients. The diagnosis must be histological and determination of BRAF status has to be performed in patients with stage >= III. Stage I-III resectable melanomas will be treated surgically. In patients with stage III melanoma, adjuvant treatment with immunotherapy or targeted therapy is also recommended. Patients with unresectable or metastatic melanoma will receive treatment with immunotherapy or targeted therapy, the optimal sequence of these treatments remains unclear. Brain metastases require a separate consideration, since, in addition to systemic treatment, they may require local treatment. Patients must be followed up closely to receive or change treatment as soon as their previous clinical condition changes, since multiple therapeutic options are available.

Filiaciones:
Majem, M:
 Hosp Santa Creu & Sant Pau, Dept Med Oncol, C St Antoni Maria Claret 167, Barcelona 08025, Spain

Manzano, JL:
 ICO Badalona, Catalan Inst Oncol, H Germans Trias & Pujol, Dept Med Oncol, Badalona, Spain

Marquez-Rodas, I:
 Inst Invest Sanitaria Gregorio Maranon, Dept Med Oncol, Madrid, Spain

 CIBERONC, Madrid, Spain

Mujika, K:
 OSI Donostialdea Onkol, UGC Oncol Gipuzkoa, Dept Med Oncol, Guipuzcoa, Spain

Munoz-Couselo, E:
 Hosp Vall dHebron Barcelona, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

Perez-Ruiz, E:
 Hosp Univ Reg Virgen Victoria, Hosp Costa Sol, Dept Med Oncol, Malaga, Spain

 Hosp Univ Reg Virgen Victoria, Inst Invest Biomed Malaga IBIMA, UGC Oncol, Malaga, Spain

de la Cruz-Merino, L:
 Hosp Univ Virgen Macarena, Dept Med Oncol, Seville, Spain

 Univ Seville, Med Dept, Seville, Spain

Espinosa, E:
 Hosp Univ La Paz, Dept Med Oncol, CIBERONC, Madrid, Spain

Gonzalez-Cao, M:
 Hosp Dexeus, Oncol Dept IOR, Barcelona, Spain

Berrocal, A:
 Consorcio Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain
ISSN: 1699048X
Editorial
SPRINGER INTERNATIONAL PUBLISHING AG, GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND, España
Tipo de documento: Article
Volumen: 23 Número: 5
Páginas: 948-960
WOS Id: 000624437100001
ID de PubMed: 33651321
imagen Green Published, hybrid

MÉTRICAS